Buy Or Sell Opportunity • Jul 14
Now 20% overvalued Over the last 90 days, the stock has fallen 13% to CN¥13.31. The fair value is estimated to be CN¥11.09, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years. Earnings per share has grown by 2.7%. Revenue is forecast to grow by 29% in 2 years. Earnings are forecast to grow by 34% in the next 2 years. Ankündigung • Jun 30
Centre Testing International Group Co. Ltd. to Report First Half, 2026 Results on Aug 17, 2026 Centre Testing International Group Co. Ltd. announced that they will report first half, 2026 results on Aug 17, 2026 Ankündigung • Dec 31
Centre Testing International Group Co. Ltd. to Report Fiscal Year 2025 Results on Mar 31, 2026 Centre Testing International Group Co. Ltd. announced that they will report fiscal year 2025 results on Mar 31, 2026 Ankündigung • Oct 17
Centre Testing International Group Co. Ltd. (SZSE:300012) acquired Laboratoire Midac. Centre Testing International Group Co. Ltd. (SZSE:300012) acquired Laboratoire Midac on October 15, 2025.
MBA Capital acted as financial advisor for Laboratoire Midac.
Centre Testing International Group Co. Ltd. (SZSE:300012) completed the acquisition of Laboratoire Midac on October 15, 2025. Ankündigung • Sep 30
Centre Testing International Group Co. Ltd. to Report Q3, 2025 Results on Oct 27, 2025 Centre Testing International Group Co. Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025 Ankündigung • Jul 02
Centre Testing International Group Co. Ltd. to Report First Half, 2025 Results on Aug 22, 2025 Centre Testing International Group Co. Ltd. announced that they will report first half, 2025 results on Aug 22, 2025 Ankündigung • May 22
Centre Testing International Group Co. Ltd. Announces Final Cash Dividend Plan on A Shares for 2024, Payable on 28 May 2025 Centre Testing International Group Co. Ltd. announced final profit distribution plan on A shares: Cash dividend/10 shares (tax included) of CNY 1.00000000 for the year 2024. Record date is 27 May 2025. Ex-date is 28 May 2025. Payment date is 28 May 2025. Ankündigung • Apr 18
Centre Testing International Group Co. Ltd., Annual General Meeting, May 19, 2025 Centre Testing International Group Co. Ltd., Annual General Meeting, May 19, 2025, at 14:30 China Standard Time. Location: No. 4, Liuxian 3rd Road, Xin'an Subdistrict, Bao'an District, Shenzhen, Guangdong China Ankündigung • Mar 31
Centre Testing International Group Co. Ltd. to Report Q1, 2025 Results on Apr 18, 2025 Centre Testing International Group Co. Ltd. announced that they will report Q1, 2025 results on Apr 18, 2025 Ankündigung • Dec 31
Centre Testing International Group Co. Ltd. to Report Fiscal Year 2024 Results on Apr 18, 2025 Centre Testing International Group Co. Ltd. announced that they will report fiscal year 2024 results on Apr 18, 2025 Buy Or Sell Opportunity • Nov 05
Now 24% overvalued after recent price rise Over the last 90 days, the stock has risen 24% to CN¥14.65. The fair value is estimated to be CN¥11.80, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 8.1%. Revenue is forecast to grow by 27% in 2 years. Earnings are forecast to grow by 35% in the next 2 years. Reported Earnings • Oct 25
Third quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.19 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.19 (in line with 3Q 2023). Revenue: CN¥1.61b (up 5.7% from 3Q 2023). Net income: CN¥310.1m (flat on 3Q 2023). Profit margin: 19% (down from 21% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Oct 18
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 33% to CN¥14.75. The fair value is estimated to be CN¥12.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 10%. Revenue is forecast to grow by 31% in 2 years. Earnings are forecast to grow by 37% in the next 2 years. New Risk • Sep 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Buy Or Sell Opportunity • Sep 30
Now 24% overvalued after recent price rise Over the last 90 days, the stock has risen 58% to CN¥15.04. The fair value is estimated to be CN¥12.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 10%. Revenue is forecast to grow by 31% in 2 years. Earnings are forecast to grow by 36% in the next 2 years. Ankündigung • Sep 30
Centre Testing International Group Co. Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Centre Testing International Group Co. Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024 Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to CN¥13.06, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 17x in the Professional Services industry in China. Total loss to shareholders of 48% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.07 per share. Reported Earnings • Aug 12
Second quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.17 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.18 (up from CN¥0.17 in 2Q 2023). Revenue: CN¥1.60b (up 11% from 2Q 2023). Net income: CN¥304.1m (up 7.1% from 2Q 2023). Profit margin: 19% (in line with 2Q 2023). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings. Board Change • Aug 02
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Director Guancheng Qi was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Jul 09
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥11.27, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 14x in the Professional Services industry in China. Total loss to shareholders of 63% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.77 per share. Ankündigung • Jul 05
Centre Testing International Group Co. Ltd. (SZSE:300012) announces an Equity Buyback for 3,000,000 shares, for CNY 50.49 million. Centre Testing International Group Co. Ltd. (SZSE:300012) announces a share repurchase program. Under the program, the company will repurchase up to 3,000,000 shares for a total purchase price of not more than CNY 50.49 million. The shares will be repurchased at a price not more than CNY 16.83 per share. The program will be funded using the company's own funds. The repurchased shares will be used for employee stock ownership plans or equity incentives. The program will be valid for a period of 12 months. Ankündigung • Jun 29
Centre Testing International Group Co. Ltd. to Report First Half, 2024 Results on Aug 12, 2024 Centre Testing International Group Co. Ltd. announced that they will report first half, 2024 results on Aug 12, 2024 Declared Dividend • May 20
Dividend of CN¥0.10 announced Shareholders will receive a dividend of CN¥0.10. Ex-date: 24th May 2024 Payment date: 24th May 2024 Dividend yield will be 0.8%, which is lower than the industry average of 1.5%. Sustainability & Growth Dividend is well covered by both earnings (19% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 51% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Buy Or Sell Opportunity • Apr 29
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 10% to CN¥12.95. The fair value is estimated to be CN¥10.39, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 37% in the next 2 years. Reported Earnings • Apr 20
First quarter 2024 earnings released: EPS: CN¥0.079 (vs CN¥0.086 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.079 (down from CN¥0.086 in 1Q 2023). Revenue: CN¥1.19b (up 6.7% from 1Q 2023). Net income: CN¥132.5m (down 8.1% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings. Ankündigung • Apr 20
Centre Testing International Group Co. Ltd., Annual General Meeting, May 10, 2024 Centre Testing International Group Co. Ltd., Annual General Meeting, May 10, 2024, at 14:30 China Standard Time. Location: No. 4, Liuxian 3rd Road, Xin'an Subdistrict, Bao'an District, Shenzhen, Guangdong China Buy Or Sell Opportunity • Apr 12
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 12% to CN¥11.54. The fair value is estimated to be CN¥14.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 19%. For the next 3 years, revenue is forecast to grow by 13% per annum. Earnings are also forecast to grow by 12% per annum over the same time period. Ankündigung • Mar 30
Centre Testing International Group Co. Ltd. to Report Q1, 2024 Results on Apr 19, 2024 Centre Testing International Group Co. Ltd. announced that they will report Q1, 2024 results on Apr 19, 2024 Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥13.39, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 14x in the Professional Services industry in China. Total loss to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.30 per share. Buy Or Sell Opportunity • Jan 25
Now 21% overvalued Over the last 90 days, the stock has fallen 11% to CN¥13.45. The fair value is estimated to be CN¥11.09, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 19%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 14% per annum over the same time period. Valuation Update With 7 Day Price Move • Jan 18
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥11.35, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Professional Services industry in China. Total loss to shareholders of 59% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥17.57 per share. Ankündigung • Dec 29
Centre Testing International Group Co. Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024 Centre Testing International Group Co. Ltd. announced that they will report fiscal year 2023 results on Apr 23, 2024 Buying Opportunity • Dec 25
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 25%. The fair value is estimated to be CN¥17.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 19%. For the next 3 years, revenue is forecast to grow by 16% per annum. Earnings is also forecast to grow by 18% per annum over the same time period. Reported Earnings • Oct 25
Third quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.19 (up from CN¥0.18 in 3Q 2022). Revenue: CN¥1.53b (up 5.7% from 3Q 2022). Net income: CN¥312.7m (up 3.4% from 3Q 2022). Profit margin: 21% (in line with 3Q 2022). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 11
Second quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.14 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.17 (up from CN¥0.14 in 2Q 2022). Revenue: CN¥1.44b (up 14% from 2Q 2022). Net income: CN¥283.9m (up 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Ankündigung • Jul 01
Centre Testing International Group Co. Ltd. to Report First Half, 2023 Results on Aug 18, 2023 Centre Testing International Group Co. Ltd. announced that they will report first half, 2023 results on Aug 18, 2023 Ankündigung • May 17
Centre Testing International Group Co. Ltd. (SZSE:300012) announces an Equity Buyback for CNY 125 million worth of its shares. Centre Testing International Group Co. Ltd. (SZSE:300012) announces a share repurchase program. Under the program, the company will repurchase up to CNY 125 million worth of its shares. The program will be valid for a period of 12 months. Reported Earnings • Apr 26
First quarter 2023 earnings released: EPS: CN¥0.086 (vs CN¥0.071 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.086 (up from CN¥0.071 in 1Q 2022). Revenue: CN¥1.12b (up 23% from 1Q 2022). Net income: CN¥144.3m (up 20% from 1Q 2022). Profit margin: 13% (in line with 1Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 01
Full year 2022 earnings released: EPS: CN¥0.54 (vs CN¥0.45 in FY 2021) Full year 2022 results: EPS: CN¥0.54 (up from CN¥0.45 in FY 2021). Revenue: CN¥5.13b (up 19% from FY 2021). Net income: CN¥902.3m (up 21% from FY 2021). Profit margin: 18% (in line with FY 2021). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 21% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Ankündigung • Jan 04
Centre Testing International Group Co. Ltd. Announces Management Elections Centre Testing International Group Co. Ltd. at its EGM held on December 30, 2022 approved election of Liu Jidi as non-independent directors, Cheng Haijin, Zeng Fanli and Liu Zhiquan as independent directors and Du Xuezhi as non-employee supervisors. Board Change • Jan 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. Supervisor Jin Ou was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Oct 27
Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.15 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.18 (up from CN¥0.15 in 3Q 2021). Revenue: CN¥1.44b (up 20% from 3Q 2021). Net income: CN¥302.3m (up 20% from 3Q 2021). Profit margin: 21% (in line with 3Q 2021). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 26
Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.12 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.14 (up from CN¥0.12 in 2Q 2021). Revenue: CN¥1.26b (up 21% from 2Q 2021). Net income: CN¥241.1m (up 20% from 2Q 2021). Profit margin: 19% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 23%, compared to a 33% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 19% per year. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥0.071 (vs CN¥0.06 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.071 (up from CN¥0.06 in 1Q 2021). Revenue: CN¥907.7m (up 19% from 1Q 2021). Net income: CN¥119.8m (up 20% from 1Q 2021). Profit margin: 13% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 24%, compared to a 29% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 29% per year. Reported Earnings • Feb 28
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Full year 2021 results: EPS: CN¥0.45 (up from CN¥0.35 in FY 2020). Revenue: CN¥4.33b (up 21% from FY 2020). Net income: CN¥745.7m (up 29% from FY 2020). Profit margin: 17% (in line with FY 2020). Revenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to grow 22%, compared to a 31% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.15 (vs CN¥0.12 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥1.20b (up 19% from 3Q 2020). Net income: CN¥252.4m (up 23% from 3Q 2020). Profit margin: 21% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 62% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Aug 27
Second quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.11 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥1.05b (up 19% from 2Q 2020). Net income: CN¥201.2m (up 12% from 2Q 2020). Profit margin: 19% (down from 20% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has increased by 68% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 04
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥29.25, the stock trades at a forward P/E ratio of 60x. Average forward P/E is 34x in the Professional Services industry in China. Total returns to shareholders of 419% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥13.75 per share. Reported Earnings • Apr 21
Full year 2020 earnings released: EPS CN¥0.35 (vs CN¥0.29 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥3.57b (up 12% from FY 2019). Net income: CN¥577.6m (up 21% from FY 2019). Profit margin: 16% (up from 15% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has increased by 86% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Feb 27
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥24.43, the stock is trading at a trailing P/E ratio of 78.9x, down from the previous P/E ratio of 95.8x. This compares to an average P/E of 29x in the Professional Services industry in China. Total returns to shareholders over the past three years are 495%. Is New 90 Day High Low • Jan 22
New 90-day high: CN¥31.35 The company is up 22% from its price of CN¥25.61 on 23 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is down 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥7.27 per share. Is New 90 Day High Low • Jan 05
New 90-day high: CN¥27.83 The company is up 14% from its price of CN¥24.43 on 30 September 2020. The Chinese market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥8.62 per share. Is New 90 Day High Low • Nov 03
New 90-day high: CN¥27.64 The company is up 6.0% from its price of CN¥25.96 on 05 August 2020. The Chinese market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥7.43 per share. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥514.4m, up 9.7% from the prior year. Total revenue was CN¥3.33b over the last 12 months, up 9.0% from the prior year. Analyst Estimate Surprise Post Earnings • Oct 28
Third-quarter earnings released: Revenue misses expectations Third-quarter revenue missed analyst estimates by 3.6% at CN¥1.01b. Revenue is forecast to grow 27% over the next year, compared to a 33% growth forecast for the Professional Services industry in China. 
